Biostatistical Software
ID: PANDHA-25-P-0000012867Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Software Publishers (513210)

PSC

IT AND TELECOM - APPLICATION DEVELOPMENT SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A20)

Original Source

https://sam.gov/opp/41ea1e8cf89c4455aebc28e60a9984be/view
Timeline
  1. 1
    Posted Apr 8, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 8, 2025, 12:00 AM UTC
  3. 3
    Due Apr 23, 2025, 8:00 PM UTC
Description

The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for biostatistical software solutions, specifically targeting Cytel’s East Horizon software and its associated modules. The objective is to identify commercial items that can fulfill specific biostatistical requirements essential for meeting FDA regulatory standards in medical research. This RFI is crucial for gathering insights into available software that supports various clinical trial designs and statistical analyses across the ORA portfolios. Interested vendors are encouraged to submit white papers by April 23, 2025, to Matthew Gembe at matthew.w.gembe.civ@health.mil, with all submissions treated as proprietary and not returned.

Point(s) of Contact
Matthew Gembe
(301) 619-1350
matthew.w.gembe.civ@health.mil
Files
Title
Posted
B01. RFI Biostatistical Software for MRDC ORA Program Office.docx
Apr 8, 2025, 5:05 PM UTC
The Medical Research & Development Command (DHA R&D - MRDC) is issuing a Request for Information (RFI) to gather insights on biostatistical software solutions, specifically focused on Cytel’s East Horizon software and its modules. This RFI aims to determine the availability of commercial items that meet specific biostatistical requirements essential for FDA regulatory standards. Interested vendors are invited to submit white papers outlining their offerings by April 23, 2025, via electronic submission. The modules requested include features for various clinical trial designs, statistical analysis, and study management to assist in study designs across ORA portfolios. The government disclaims any obligation arising from submissions, stressing that this process is for information gathering rather than a formal solicitation. The document outlines submission guidelines, including formatting, point of contact details, and clarifications around proprietary information handling. Overall, this RFI serves to facilitate market research for suitable biostatistical tools that help meet the rigor of medical research demands within government parameters.
Lifecycle
Title
Type
Biostatistical Software
Currently viewing
Sources Sought
Similar Opportunities
Chemistry Analyzers - Eglin, AFB Florida
Buyer not available
The Defense Health Agency (DHA) is conducting market research to identify potential sources for providing Chemistry Analyzers at Eglin Air Force Base, Florida. The requirement includes delivering integrated chemistry and immune-chemistry platforms that comply with military standards, perform a specified range of tests, and ensure robust software capabilities, including interfaces with the DHA MHS GENESIS electronic health record system. This procurement is crucial for enhancing medical testing capabilities within the Department of Defense while adhering to regulatory standards, including HIPAA for the protection of health information. Interested parties must submit their responses to the Request for Information (RFI) by 12:00 P.M. Central Time on May 1, 2025, and can direct inquiries to Robby Brinkmann at robert.t.brinkmann.civ@health.mil or Marcus Mattingly at marcus.h.mattingly.civ@health.mil.
Ambr 250 High Throughput Bioreactor System
Buyer not available
The Department of Defense, through the Defense Health Agency, is seeking to procure an Ambr 250 High Throughput Bioreactor System for the Pilot Bioproduction Facility at the Walter Reed Army Institute of Research in Silver Spring, Maryland. This procurement aims to enhance capabilities for monoclonal antibody production, allowing for simultaneous testing of multiple conditions to accelerate the manufacturing of vaccines and biologics for military-relevant infectious diseases. The system must meet specific Minimum Essential Characteristics, including the ability to process up to 12 cultures, automated controls for critical parameters, and compliance with FDA regulations, particularly 21 CFR Part 11 for data integrity. Interested vendors should note that the anticipated solicitation release is on April 10, 2025, with a contract performance period from June 1, 2025, to May 31, 2029. For further inquiries, contact Ms. Brenda Mena at brenda.i.mena.civ@health.mil or Ms. Sharew Hailu at sharew.hailu.civ@health.mil.
Transfusion Services
Buyer not available
The Department of Defense, through the Medical Regional Contracting Office-West (MRCO-W), is seeking potential sources for a software solution to manage tracking and tracing of biologic and non-biologic implants at Brooke Army Medical Center. The procurement requires licenses for 70 individual users to access the Tracs4Life system, with a performance period from September 1, 2025, to August 31, 2026, and four optional renewal years. This software is crucial for maintaining compliance with regulatory standards set by organizations such as TJC, CAP, AABB, and the FDA for tissue specimen management. Interested parties must submit their responses, including company identification and a ten-page capability statement, by 4:00 PM CST on May 1, 2025, to Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.
Hematology Analyzers - Eglin AF, Florida
Buyer not available
The Defense Health Agency (DHA) is conducting market research to identify potential sources for providing and delivering Hematology Analyzers at Eglin Air Force Base, Florida. The procurement aims to enhance healthcare capabilities within the military medical system by acquiring two integrated hematology analyzers that comply with Department of Defense specifications and meet rigorous accuracy standards as defined by the Clinical Laboratory Improvement Act. Interested firms are encouraged to submit their capabilities and qualifications by May 1, 2025, to Mr. Robby Brinkmann at robert.t.brinkmann.civ@health.mil, with the possibility of the contract being set aside for small businesses based on responses received.
Health Care Delivery IT Solutions (MHS GENESIS) Documentation
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking small businesses to provide documentation services for the MHS GENESIS electronic health record system. The primary objective is to revise and update existing technical documentation to ensure it is comprehensive and understandable for third parties, facilitating future responses to requests for proposals (RFPs) and ongoing maintenance of the system. MHS GENESIS is a complex system that integrates various health record components and serves over 9.6 million beneficiaries, making accurate documentation critical for operational efficiency and compliance. Interested parties must submit their capability statements by April 28, 2025, to the designated email address, with a maximum of seven pages for their response.
Research and Development of the FDA ARGOS System
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the research and development of the FDA ARGOS System, as outlined in a Sources Sought Notice. The primary objective is to enhance the FDA ARGOS database and develop bioinformatics and artificial intelligence tools to analyze genetic data, thereby improving public health preparedness and regulatory processes related to medical countermeasures against infectious diseases. This initiative is crucial for advancing diagnostic capabilities through Next Generation Sequencing (NGS) technology, which can identify microbial pathogens efficiently and accurately. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by May 2, 2025, at 2:00 PM EST, as no solicitation is currently available.
Request for Proposals: On-Premises Intellectual Property (IP) and Technology Transfer (T2) Database and Related Services
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity (USAMRAA), is soliciting proposals for an On-Premises Intellectual Property (IP) and Technology Transfer (T2) Database and related services. The procurement aims to acquire a Commercial Patent Docketing and Database Software System to support the United States Army Medical Research and Development Command (USAMRDC) in managing patenting and licensing processes, ensuring compliance with legal requirements, and enhancing data management capabilities. This initiative is critical for effective intellectual property management within the medical research community, with the contract expected to be awarded by May 12, 2025. Interested parties should direct inquiries to Lisa Kuhns at 301-619-2336 or via email at lisa.z.kuhns.civ@health.mil, and proposals must adhere to the specified submission guidelines to be considered.
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) related to pharmaceutical agents for the Military Health System's Uniform Formulary (UF). This procurement aims to establish effective and efficient pharmacy benefits, ensuring that selected pharmaceutical agents are evaluated for their clinical and cost-effectiveness as mandated by law. The upcoming Pharmacy and Therapeutics (P&T) Committee meeting, scheduled for May 7-8, 2025, will review newly approved drugs, with quotes due by April 17, 2025. Interested manufacturers should direct inquiries to Keith Marasigan at keith.b.marasigan2.ctr@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil for further details.
Master BPA - Tissue Staining Chemical Analyzer and Services
Buyer not available
The Defense Health Agency (DHA) is conducting a sources sought announcement for the procurement of tissue staining chemical analyzers and associated services, specifically targeting the Walter Reed National Military Medical Clinic in Bethesda, Maryland. The agency seeks to acquire commercial items, including the Bench Mark Ultra, Bench Mark Ultra Plus, and Ventana HE 600 analyzers, along with necessary reagents and operational services to ensure proper functionality. These analyzers play a critical role in laboratory diagnostics, enhancing the capabilities of healthcare providers within the military medical system. Interested parties are encouraged to submit non-proprietary capabilities statements by April 28, 2025, at 09:00 AM EST, with inquiries directed to Claudia Febres Mormontoy at claudia.a.febresmormontoy.ctr@health.mil or Faatalivale Te’o-Lewis at Faatalivale.m.teo-lewis.civ@health.mil.
LEGACY DATA CONSOLIDATION SOLUTION – HEALTH INFORMATION ARCHIVE
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract to Mediquant, LLC for the provision of Health Information Archive (HIA) services aimed at consolidating legacy data and maintaining software systems. This contract will support the Enterprise Intelligence and Data Solutions (EIDS) Program Management Office (PMO) by mapping and loading data sets into Mediquant's proprietary data model and ensuring the operational integrity of the HIA, which is crucial for managing health-related information. The contract is expected to be a Firm Fixed-Price agreement with a base period of 12 months and four additional option periods, with an anticipated award date no later than December 2024. Interested parties may express their capabilities to Domonique Holmes via email at domonique.p.holmes.civ@health.mil within 7 calendar days of this notice.